FDA Inspection
Zhejiang Xianju Junye Pharmaceutical Co., Ltd.Zhejiang Xianju Junye Pharmaceutical Co., Ltd. – FDA Inspection, Jan 11, 2019
Record Details
This FDA Inspection record concerns Zhejiang Xianju Junye Pharmaceutical Co., Ltd., with an inspection on January 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 11, 2019
- Product Type
- Drugs
- Person
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · cf1bbba6-7d10-4995-8881-4a28f1b65eb7
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1080056
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2025 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
- FDA Inspection 1280280 - 2025-07-11
- FDA Inspection 918373 - 2015-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.